eFinder

eFinder

Home › Drug Discovery Acceleration › Article

OpenAI launches new AI model for life sciences research

Axios · · 482 words · By Megan Morrone
Drug Discovery Acceleration AI Safety and Biosecurity AI in Life Sciences

OpenAI has introduced GPT-Rosalind, a new series of AI models designed to assist life sciences researchers in fields such as genomics and biochemistry. The models are being released via a limited 'trusted access program' to qualified enterprise customers to balance research acceleration with security and safety concerns.

open_in_new Read the original article: https://axios.com/2026/04/16/openai-models-life-sciences-drugs

analyticsAnalysis

10%
Propaganda Score
confidence: 95%
Low risk. This article shows minimal use of propaganda techniques.

psychologyDetected Techniques

warning
Loaded Language 70% confidence
Using words with strong emotional connotations to influence an audience.

fact_checkFact-Check Results

13 claims extracted and verified against multiple sources including cross-references, web search, and Wikipedia.

check_circle Corroborated 7
schedule Pending 3
help Insufficient Evidence 2
verified Verified 1
check_circle
“OpenAI announced a new series of AI models built to help life sciences researchers work faster.”
CORROBORATED
Multiple independent sources (Bloomberg, OpenAI's own announcement, and other news reports) confirm that OpenAI announced a new series of AI models for life sciences research.
travel_explore
web search NEUTRAL — OpenAI announced a new series of AI models built to help life sciences researchers work faster. Why it matters: Biology research is increasingly computational, but scientists are drowning in data acro…
https://www.axios.com/2026/04/16/openai-models-life-sciences…
travel_explore
web search NEUTRAL — OpenAI has launched GPT-Rosalind, a frontier reasoning model built specifically for life sciences research, the company announced on Thursday. The model is designed to support evidence synthesis, hypo…
https://thenextweb.com/news/openai-gpt-rosalind-life-science…
travel_explore
web search NEUTRAL — Joy Jiao, who leads OpenAI’s life science research, said the company hopes the model can act as a research partner for businesses using it, particularly for biology work that is increasingly reliant o…
https://www.bloomberg.com/news/articles/2026-04-16/openai-ta…
check_circle
“Right now it takes roughly 10 to 15 years to go from target discovery to regulatory approval for new drugs in the U.S., according to OpenAI.”
CORROBORATED
Multiple web sources explicitly state that OpenAI cited the 10 to 15 year timeline from target discovery to regulatory approval for new drugs in the U.S.
menu_book
wikipedia NEUTRAL — OpenAI is an American artificial intelligence (AI) research organization headquartered in San Francisco, consisting of a for-profit public benefit corporation (PBC) partially controlled by a nonprofit…
https://en.wikipedia.org/wiki/OpenAI
menu_book
wikipedia NEUTRAL — Sora was a text-to-video model and social media app developed by OpenAI. Using artificial intelligence, the model generated short video clips based on prompts, and could also extend existing short vid…
https://en.wikipedia.org/wiki/Sora_(text-to-video_model)
menu_book
wikipedia NEUTRAL — Anthropic is an American artificial intelligence (AI) company headquartered in San Francisco. It has developed a range of large language models (LLMs) named Claude and focuses on AI safety. Anthropic …
https://en.wikipedia.org/wiki/Anthropic
+ 3 more evidence sources
check_circle
“Only one in 10 drugs entering clinical trials ultimately gets approved.”
CORROBORATED
Multiple sources confirm that approximately 10% (or slightly more, e.g., 12.8%) of drugs entering clinical trials receive approval. This is reported both in the context of OpenAI's claims and by general scientific sources.
menu_book
wikipedia NEUTRAL — In statistics, an approximate entropy (ApEn) is a technique used to quantify the amount of regularity and the unpredictability of fluctuations over time-series data. For example, consider two series o…
https://en.wikipedia.org/wiki/Approximate_entropy
menu_book
wikipedia NEUTRAL — In mathematics, particularly in functional analysis and ring theory, an approximate identity is a net in a Banach algebra or ring (generally without an identity) that acts as a substitute for an ident…
https://en.wikipedia.org/wiki/Approximate_identity
menu_book
wikipedia NEUTRAL — An approximation is anything that is intentionally similar but not exactly equal to something else.
https://en.wikipedia.org/wiki/Approximation
+ 3 more evidence sources
check_circle
“More than 30 million Americans and 300 million people globally living with rare diseases are waiting for better treatments.”
CORROBORATED
Multiple independent sources confirm that over 300 million people worldwide live with rare diseases. While the specific '30 million Americans' figure is not explicitly detailed in the snippets, the global figure is strongly corroborated.
menu_book
wikipedia NEUTRAL — The .300 Winchester Magnum (also known as .300 Win Mag or .300 WM) (7.62×67mmB, 7.62×66BR) is a belted, bottlenecked magnum rifle cartridge that was introduced by the Winchester Repeating Arms Company…
https://en.wikipedia.org/wiki/.300_Winchester_Magnum
menu_book
wikipedia NEUTRAL — The S-300 (NATO reporting name SA-10 Grumble) is a series of long-range surface-to-air missile systems developed by the former Soviet Union. It was produced by NPO Almaz for the Soviet Air Defence For…
https://en.wikipedia.org/wiki/S-300_missile_system
menu_book
wikipedia NEUTRAL — The United States of America (USA), also known as the United States (U.S.) or America, is a country primarily located in North America. It is a federal republic consisting of 50 states and a federal c…
https://en.wikipedia.org/wiki/United_States
+ 3 more evidence sources
check_circle
“OpenAI designed the first Life Sciences model — GPT-Rosalind — to be better at fundamental reasoning in fields like biochemistry and genomics”
CORROBORATED
Multiple sources confirm the launch of GPT-Rosalind and its focus on biochemistry, genomics, and protein reasoning.
travel_explore
web search NEUTRAL — OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
https://openai.com/index/introducing-gpt-rosalind/
travel_explore
web search NEUTRAL — Life sciences model helps scientists make faster and better decisions by combining structured data retrieval, literature search, and scientific analysis into a repeatable workflow in codecs. In this i…
https://www.linkedin.com/posts/openai_introducing-gptrosalin…
travel_explore
web search NEUTRAL — OpenAI announced a new series of AI models built to help life sciences researchers work faster. Why it matters: Biology research is increasingly computational, but scientists are drowning in data acro…
https://www.axios.com/2026/04/16/openai-models-life-sciences…
verified
“OpenAI named the model after British chemist Rosalind Franklin, whose research helped reveal the structure of DNA and laid the foundation for modern molecular biology.”
VERIFIED
Web sources confirm the model is named after Rosalind Franklin, and Wikipedia provides authoritative confirmation of her identity as a British chemist whose work was central to understanding DNA structure.
menu_book
wikipedia NEUTRAL — The following scientific events occurred in 2023.
https://en.wikipedia.org/wiki/2023_in_science
menu_book
wikipedia NEUTRAL — Rosalind Elsie Franklin (25 July 1920 – 16 April 1958) was an English chemist and X-ray crystallographer. Her work was central to the understanding of the molecular structures of DNA (deoxyribonucleic…
https://en.wikipedia.org/wiki/Rosalind_Franklin
travel_explore
web search NEUTRAL — OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
https://openai.com/index/introducing-gpt-rosalind/
+ 2 more evidence sources
check_circle
“The model includes "enterprise-grade security controls" and access management, suitable for highly-regulated scientific environments, per OpenAI.”
CORROBORATED
Multiple sources report that OpenAI stated GPT-Rosalind includes enterprise-grade security controls and access management for regulated environments.
travel_explore
web search NEUTRAL — Analyze OpenAI's GPT-Rosalind, a biochemical reasoning model for life sciences. Learn how Amgen, Moderna, and Thermo Fisher apply this AI to drug discovery.The model has “enterprise-grade security con…
https://intuitionlabs.ai/articles/openai-gpt-rosalind-bioche…
travel_explore
web search NEUTRAL — In response, OpenAI stated that GPT-Rosalind had been developed with enterprise-grade security controls, strict access management and governance requirements to ensure responsible use in regulated env…
https://www.manufacturingchemist.com/openai-launches-gpt-ros…
travel_explore
web search NEUTRAL — How will OpenAI expand access to GPT-Rosalind for researchers outside the US?How does OpenAI plan to address concerns around data privacy and security with GPT-Rosalind?...GPT-Rosalind, including encr…
https://www.nowadais.com/gpt-rosalind-life-sciences-model-la…
check_circle
“The company already partners with Los Alamos National Laboratory on AI-guided protein and catalyst design.”
CORROBORATED
Multiple sources (Bloomberg, Neowin) confirm a partnership between OpenAI and Los Alamos National Laboratory involving AI for scientific research and deployment on the Venado supercomputer.
travel_explore
web search NEUTRAL — Named after Rosalind Franklin, OpenAI's newest model is purpose-built for biochemistry, genomics, and protein engineering.OpenAI just announced GPT-Rosalind, a new specialized AI model built exclusive…
https://www.neowin.net/news/openai-goes-after-google-deepmin…
travel_explore
web search NEUTRAL — The Microsoft-backed AI maker today announced a US national lab partnership that will start with deployment of its reasoning-capable o1 LLM on Los Alamos National Laboratory's (LANL) Venado supercompu…
https://www.theregister.com/2025/01/30/openai_los_alamos_nat…
travel_explore
web search NEUTRAL — OpenAI is teaming up with Los Alamos National Laboratory, best known for developing the world’s first atomic bomb, to study the opportunities and risks for using artificial intelligence systems to ass…
https://www.bloomberg.com/news/articles/2024-07-10/openai-pa…
help
“Only a few AI-discovered or AI-designed drugs have reached clinical trials.”
INSUFFICIENT EVIDENCE
No evidence was provided in the search results to confirm or deny the number of AI-discovered drugs in clinical trials.
help
“No fully AI-discovered or AI-designed drug has made it through phase 3 trials.”
INSUFFICIENT EVIDENCE
No evidence was provided in the search results to confirm or deny whether any fully AI-designed drug has completed phase 3 trials.
schedule
“An international group of more than 100 scientists have called for tighter controls on sensitive biological data used to train AI systems, Axios reported earlier this year.”
PENDING
schedule
“OpenAI is launching the models in research preview to select enterprise customers through a "trusted access program."”
PENDING
schedule
“It will be available Thursday for what OpenAI calls "qualified customers," including Amgen, Moderna, the Allen Institute, and Thermo Fisher Scientific.”
PENDING
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.